Actithera is a molecular radiotherapeutic company that develops radioligand therapies.
Actithera has raised $75.5M in total funding. The most recent round was Series A. The last funding was announced in July 2025.
Actithera's investors include Sofinnova Partners, Innovestor, Hadean Ventures, 4BIO Capital, Investinor.
Actithera is headquartered in Oslo, Norway.
Actithera is a molecular radiotherapeutic company that develops radioligand therapies.
Actithera is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Actithera — Funding & Investors." VCBacked, July 9, 2025, https://www.vcbacked.co/company/actithera. Accessed October 31, 2026.
VCBacked. (2025). Actithera — Funding & Investors. Retrieved October 31, 2026, from https://www.vcbacked.co/company/actithera
{{cite web |title=Actithera — Funding & Investors |url=https://www.vcbacked.co/company/actithera |website=VCBacked |access-date=October 31, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated